Solara Active Pharma Sciences Limited — Updates, 19-11-2025: Press Release
19-11-2025 | 10:26 am
19-11-2025 | 10:26 am
Solara's Mangalore API facility cleared its US FDA inspection with a 'Voluntary Action Indicated (VAI)' classification. This confirms strong ongoing cGMP compliance, a key positive for its manufacturing profile.
No comments yet. Be the first to comment!
All announcements from Solara Active Pharma Sciences Limited
